BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36266381)

  • 1. Will SARS-COV-2 infection accelerate the incidence of Alzheimer's disease in Down syndrome population?
    Barišić A; Vraneković J
    Aging Clin Exp Res; 2022 Nov; 34(11):2919-2920. PubMed ID: 36266381
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
    Illouz T; Biragyn A; Frenkel-Morgenstern M; Weissberg O; Gorohovski A; Merzon E; Green I; Iulita F; Flores-Aguilar L; Dierssen M; De Toma I; Lifshitz H; Antonarakis SE; Yu E; Herault Y; Potier MC; Botté A; Roper R; Sredni B; Sarid R; London J; Mobley W; Strydom A; Okun E
    Neuromolecular Med; 2021 Dec; 23(4):561-571. PubMed ID: 33660221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible unitary genetic hypothesis for Alzheimer's disease and Down syndrome.
    Schweber M
    Ann N Y Acad Sci; 1985; 450():223-38. PubMed ID: 3160290
    [No Abstract]   [Full Text] [Related]  

  • 4. Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients.
    Newman AM; Jhaveri R; Patel AB; Tan TQ; Toia JM; Arshad M
    J Pediatr; 2021 Jan; 228():294-296. PubMed ID: 32861693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down syndrome and incidence of Alzheimer's disease.
    Smith DS
    Am Fam Physician; 1998 Apr; 57(7):1498. PubMed ID: 9556640
    [No Abstract]   [Full Text] [Related]  

  • 6. Aging With Down Syndrome: The Dual Diagnosis: Alzheimer's Disease and Down Syndrome.
    Cipriani G; Danti S; Carlesi C; Di Fiorino M
    Am J Alzheimers Dis Other Demen; 2018 Jun; 33(4):253-262. PubMed ID: 29504408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Season of birth: dementia in Alzheimer's disease in adults with Down Syndrome.
    Prasher VP; Kapadia HM; Haque MS
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):441-2. PubMed ID: 17691078
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernández S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Alcolea D; Clarimón J; Zaman SH; Blesa R; Lleó A
    Lancet; 2020 Jun; 395(10242):1988-1997. PubMed ID: 32593336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical aging in Down syndrome.
    Zigman WB
    Dev Disabil Res Rev; 2013; 18(1):51-67. PubMed ID: 23949829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome.
    Mok KY; Jones EL; Hanney M; Harold D; Sims R; Williams J; Ballard C; Hardy J
    Neurobiol Aging; 2014 Jun; 35(6):1513.e1-5. PubMed ID: 24462566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from individuals with Down syndrome during COVID-19.
    Del Carmen Ortega M; Borrel JM; de Jesús Bermejo T; González-Lamuño D; Manso C; de la Torre R; Mayer MA; de Asúa DR; Dierssen M;
    Lancet Neurol; 2020 Dec; 19(12):974-975. PubMed ID: 33212059
    [No Abstract]   [Full Text] [Related]  

  • 12. The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection.
    Nuovo GJ; Suster D; Sawant D; Mishra A; Michaille JJ; Tili E
    Ann Diagn Pathol; 2022 Dec; 61():152057. PubMed ID: 36334414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms.
    Chen F; Chen Y; Wang Y; Ke Q; Cui L
    Transl Neurodegener; 2022 Sep; 11(1):40. PubMed ID: 36089575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease associated with Down syndrome: a genetic form of dementia.
    Fortea J; Zaman SH; Hartley S; Rafii MS; Head E; Carmona-Iragui M
    Lancet Neurol; 2021 Nov; 20(11):930-942. PubMed ID: 34687637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of COVID-19 with New-Onset Alzheimer's Disease.
    Wang L; Davis PB; Volkow ND; Berger NA; Kaelber DC; Xu R
    J Alzheimers Dis; 2022; 89(2):411-414. PubMed ID: 35912749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study.
    Cascini S; Agabiti N; Marino C; Acampora A; Balducci M; Calandrini E; Davoli M; Bargagli AM
    J Alzheimers Dis; 2022; 89(2):681-693. PubMed ID: 35912744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer-type dementia and Down syndrome].
    Johannsen P; Mai J
    Ugeskr Laeger; 1995 Feb; 157(8):1021-4. PubMed ID: 7879299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dementia of Down's syndrome and its relevance to aetiological studies of Alzheimer's disease.
    Whalley LJ
    Ann N Y Acad Sci; 1982; 396():39-53. PubMed ID: 6217776
    [No Abstract]   [Full Text] [Related]  

  • 19. Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome.
    Vita S; Di Bari V; Corpolongo A; Goletti D; Espinosa J; Petracca S; Palmieri F; Nicastri E;
    Int J Infect Dis; 2021 Feb; 103():607-610. PubMed ID: 33271290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.
    De Toma I; Dierssen M
    Sci Rep; 2021 Jan; 11(1):1930. PubMed ID: 33479353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.